Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Treatment selection and functional outcomes in treatment-related acute myeloid leukemia (tAML) and AML with myelodysplasia-related changes (MRC): A multicenter prospective cohort study

Vijaya Bhatt, Christopher Wichman, Joseph Maakaron, Richard Stone, Moataz Ellithi, Michael Haddadin, Lori Maness, Soroush Mortaz-Hedjri, Steven Green, Kah Poh (Melissa) Loh, Sarah Wall, Krishna Gundabolu

Blood (2025) 146 (Supplement 1): 6381.

https://doi.org/10.1182/blood-2025-6381

Published: 2025

Journal Articles

Prognostic impact of cognitive and other impairments in older adults with acute myeloid leukemia (AML) participating in a geriatric assessment-guided treatment selection trial

Vijaya Bhatt, Yue Zhan, Christopher Wichman, Thuy Koll, Tanya Wildes, Moataz Ellithi, Michael Haddadin, Lori Maness, Krishna Gundabolu

Blood (2025) 146 (Supplement 1): 3434.

https://doi.org/10.1182/blood-2025-3434

Published: 2025

Journal Articles

Phase I trial of a novel first-in-class drug ONC201 as a post-transplant maintenance for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

Vijaya Bhatt, Christopher Wichman, Alyssa Bouska, Moataz Ellithi, Michael Haddadin, Javeed Iqbal, James Talmadge, Lori Maness, Krishna Gundabolu

Blood (2025) 146 (Supplement 1): 174.

https://doi.org/10.1182/blood-2025-174

Published: 2025

Journal Articles

Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System

Magdi Elsallab, Moataz Ellithi, Matthew A. Lunning, Christopher D’Angelo, Jihyun Ma, Miguel-Angel Perales, Matthew Frigault, Marcela V. Maus

Blood (2024) 143 (20): 2099–2105.

https://doi.org/10.1182/blood.2024024166

Published: 2024

Includes: Supplemental data

Journal Articles

Clinical Outcomes in Patients Admitted with Malignancy Associated Hemophagocytic Lymphohistiocytosis (HLH)

Hafez M Abdullah, Moataz Ellithi, Faiz Anwer

Blood (2021) 138 (Supplement 1): 4199.

https://doi.org/10.1182/blood-2021-154352

Published: 2021

Journal Articles

Clinical Outcomes of Malignancy-Related Neutropenic Fever Admissions in the United States: A 10-Year National Study

Moataz Ellithi, MBBCh, Hafez M Abdullah, MD, Waqas Ullah, MD, Radowan Elnair, MD, Fouad Khalil, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-138490

Published: 2020

Journal Articles

Acute Coronary Syndrome in Patients with Thrombotic Thrombocytopenic Purpura

Moataz Ellithi, MBBCh, Fouad Khalil, MD, Smitha N Gowda, MD, Waqas Ullah, MD, Radowan Elnair, MD, Hafez M Abdullah, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-138482

Published: 2020

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

Treatment selection and functional outcomes in treatment-related acute myeloid leukemia (tAML) and AML with myelodysplasia-related changes (MRC): A multicenter prospective cohort study

Prognostic impact of cognitive and other impairments in older adults with acute myeloid leukemia (AML) participating in a geriatric assessment-guided treatment selection trial

Phase I trial of a novel first-in-class drug ONC201 as a post-transplant maintenance for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System

Clinical Outcomes in Patients Admitted with Malignancy Associated Hemophagocytic Lymphohistiocytosis (HLH)

Clinical Outcomes of Malignancy-Related Neutropenic Fever Admissions in the United States: A 10-Year National Study

Acute Coronary Syndrome in Patients with Thrombotic Thrombocytopenic Purpura

Email alerts

ASH Publications

American Society of Hematology

Update search

Treatment selection and functional outcomes in treatment-related acute myeloid leukemia (tAML) and AML with myelodysplasia-related changes (MRC): A multicenter prospective cohort study

Prognostic impact of cognitive and other impairments in older adults with acute myeloid leukemia (AML) participating in a geriatric assessment-guided treatment selection trial

Phase I trial of a novel first-in-class drug ONC201 as a post-transplant maintenance for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System

Clinical Outcomes in Patients Admitted with Malignancy Associated Hemophagocytic Lymphohistiocytosis (HLH)

Clinical Outcomes of Malignancy-Related Neutropenic Fever Admissions in the United States: A 10-Year National Study

Acute Coronary Syndrome in Patients with Thrombotic Thrombocytopenic Purpura

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only